COMPANY
Cytosolix
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. From company website Source · Oct 13, 2026
COMPANY
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. From company website Source · Oct 13, 2026